Covered transjugular intrahepatic portosystemic stent-shunt vs large volume paracentesis in patients with cirrhosis: A real-world propensity score-matched study

Table 4 Univariate analysis of selected pertinent variables predicting transplant-free survival (whole cohort)

	B	SE	Wald	Df	P value	Hazard ratio	95%CI
Age	0.011	0.010	1.259	1	0.262	1.011	0.992-1.031
Albumin	-0.086	0.021	17.127	1	< 0.001	0.917	0.880-0.955
Recurrent Ascites	-0.033	0.211	.025	1	0.874	0.967	0.640-1.462
TIPSS	-0.213	0.207	1.055	1	0.304	0.808	0.539-1.213
HCC at baseline	1.424	0.328	18.788	1	< 0.001	4.152	2.181-7.903
MELD	0.010	0.021	0.248	1	0.619	1.010	0.970-1.053
Sex (1 = male, 2 = female)	0.104	0.202	0.263	1	0.608	1.109	0.746-1.649
CPS	0.169	0.065	6.716	1	0.010	1.184	1.042-1.345
SBP	-0.068	0.251	0.074	1	0.786	0.934	0.571-1.527

B: Beta coefficient; SE: Standard error; Df: Discriminative function; CI: Confidence interval; TIPSS: Transjugular intrahepatic portosystemic stent shunt; HCC: Hepatocellular carcinoma; MELD: Model for end-stage liver disease; CPS: Childs Pugh score; SBP: Spontaneous bacterial peritonitis.